Contact Us | Useful Links | FAQs | Feedback | Sitemap |
 
   
 
Holdipharma Delegation gave a visit to the newdigging site of the Suez Canal :: Holdipharma welcomes the establishment of a production facility dedicated for production of raw materials :: Egyptian Exchange "Rings the Bell For Gender Equality " :: UNGC principles with holdipharma :: New chairman of Drug Holding Co. :: The Minister of the Business Sector is following up implementation plan :: Minister of Business Sector approved the estimated "DHC budget " 2017/2018 :: President Al Sisi directs the follow-up plans to develop public sector companies :: Minister of Business Sector receives Indian Ambassador :: Drug Holding Company: “Development Committee "ends the study of the Co. structure :: Ministry Of Public Business Sector: completion of the General Assemblies of DHCs :: Minister of Business Sector assigns 3 new members of Board of Directors of the DHC :: Chairman of Drug Holding Company: 11% is our share in the Egyptian drug market :: Captain Mohammed Wanees, one of the heroes of the glorious October War :: Minister of Business Sector: Restructuring the investment portfolio of the companies :: Appointment of a new President of the Drug Holding Company :: Hisham Anwar Tawfiq, Minister of Public Business sector, replacing Khaled Badawi . :: An integrated strategy for the advancement of the Drug Holding Company :: Dr.Ahmed Hegazy Chairman of Holdipharma Company confirm that Holdipharma reaffirms its support for the ten principles of the United Nations Global Compact ::
 
 
 
Company Details
Company Name   Website
Nile Company for Pharmaceuticals and Chemical Industries.   www.nilepharma.com.eg
     
Description

The beginning of establishment of Nile Pharmaceutical Company was initially achieved in 1962 by integration of some small national pharmaceutical labs owned by the private sector to be united under one big entity.

This idea was realized by the integration of Isis lab, Iakadel lab, Ain Shams Co. for pharmaceutical products and some other small pharmaceutical facilities beside the factory of operational sutures, all in one to become a great company named "Nile", which was opened officially in 1966 and was directed since then by the most pioneered pharmaceutical industry leaders in Egypt and Arab countries, and since that time , it became one of the largest pharmaceutical facilities in the Middle East, and that great reputation enabled the company to acquire its significant confidentiality by global multinational companies to manufacture their products under-license in Nile Co.

The company owns the latest production lines for manufacturing most of pharmaceutical dosage forms including Syrups, Large volume parenteral, the sterile area for production of lyophilized ampoules, lotions, dedicated facility for biotechnology "genetic engineering", insulin-line and disinfectants line, and all production lines is routinely audited by MOH and is totally complying with the latest guidelines of "Good Manufacturing Practices" GMP with a good controlled environmental protection to cease the industrial pollution to the surrounding.

Nile Company exports a large number of its famous products to all Arab countries and to most of surrounding African countries.

Board Members:

Dr/ Hesham Abd Elaziz   Elsayed                      Chairman Of the Board & Managing Director

Dr/ Irene Fouad Garges                                                   Non- Executive Member

Mr/ Mohsen Ali Mohamed Hussen                                     Non- Executive Member

Mr/ Mohamed Ahmed Halim                                              Non-Executive Member

Mr/ Ahmed Mohamed  Baheg                                            Non- Executive Member

Dr/ Hesham Abd Elftah  Abd Elaziz                                   Elected Board Member

Dr/ Mostafa Abd Eltoab Ebd Rabo                                     Elected Board Member

Mr/ Adel Abd Elaziz Salem                                                 Elected Board Member

Mr/ Ahmed Mohamed Abd Elrahman                                  Elected Board Member

Audit Committee:   

Mr/ Mohamed Ahmed Halim                                       Non-Executive Member  (Head)

Dr/ Irene Fouad Garges                                             Non-Executive Member

Mr/ Mohsin Ali Mohamed Mohsin                                 Non-Executive Member

Assistant Members:  Head of The Finantial Affairs Sector of The Company 

Company Main Indicators  (in thousands of Egyptian Pounds)

       

2017-2018

2016-2017

2015-2016

Indicator

459930

417742

330464

Net Operating Revenue

8923

2192

0

Interest Expenses

(17590)

23194

8656

Net Income

270438

300820

299465

Net Equity

147680

172480

181757

Working Capital

618273

825116

304564

Total Investment

147828

145640

125739

Salaries

2123

2339

2421

Number of workers

 

 

 

Image Gallery

   
     
Related Links
Affiliates
   
Joint Venture
   
   
   
   
 
 
     
  Copyright © 2009 HOLDIPHARMA. All rights reserved.         Terms of Use | Privacy Statement | Disclaimer |